Staging laparoscopy is mandatory for the treatment of pancreatic cancer to avoid missing radiologically negative metasta

  • PDF / 1,145,393 Bytes
  • 9 Pages / 595.276 x 790.866 pts Page_size
  • 82 Downloads / 182 Views

DOWNLOAD

REPORT


ORIGINAL ARTICLE

Staging laparoscopy is mandatory for the treatment of pancreatic cancer to avoid missing radiologically negative metastases Tatsuyuki Takadate1 · Takanori Morikawa1 · Masaharu Ishida1 · Shuichi Aoki1 · Tatsuo Hata1 · Masahiro Iseki1 · Takayuki Miura1 · Kyohei Ariake1 · Shimpei Maeda1 · Kei Kawaguchi1 · Kunihiro Masuda1 · Hideo Ohtsuka1 · Masamichi Mizuma1 · Hiroki Hayashi1 · Kei Nakagawa1 · Fuyuhiko Motoi1 · Takashi Kamei1 · Takeshi Naitoh1 · Michiaki Unno1 Received: 10 March 2020 / Accepted: 14 August 2020 © Springer Nature Singapore Pte Ltd. 2020

Abstract Purpose  Staging laparoscopy is considered useful for determining treatment plans for advanced pancreatic cancer. However, the indications for staging laparoscopy are not clear. This study aimed to evaluate the safety of staging laparoscopy and its usefulness for detecting distant metastases in patients with pancreatic cancer. Methods  A total of 146 patients with pancreatic cancer who underwent staging laparoscopy between 2013 and 2019 were analyzed. Staging laparoscopy was performed in all pancreatic cancer patients in whom surgery was considered possible. Results  In this cohort, 42 patients (29%) were diagnosed with malignant cells on peritoneal lavage cytology, 9 (6%) had peritoneal dissemination, and 11 (8%) had liver metastases. A total of 48 (33%) had radiologically negative metastases. On a multivariate analysis, body and tail cancer [odds ratio (OR) 5.00, 95% confidence interval (CI) 2.15–11.6, p